| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Phreesia, Inc.'s insiders have reduced their positions by a net 536 shares worth roughly $6K. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. PHR sits in the Health Care Technology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.39M | $17.38M | - | |
| Pres | 842.5K | $10.54M | - | |
| Pres | 224.1K | $2.80M | - | |
| VP | 168.9K | $2.11M | - | |
| Other | 163.5K | $2.05M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2022 | Munson Gillian54 | Director | Sell | 2,106 | $16.06 | $33,815.20 | -11.2% | +63.2% | +96.8% | |
| May 9, 2022 | Hoffman Allison C66 | General Counsel &Secretary | Sell | 3,909 | $17.07 | $66,708.17 | -1.1% | +56.0% | +69.3% | |
| Jan 19, 2022 | Rasmussen Randy66 | Chief Financial Officer | Sell | 2,228 | $32.66 | $72,766.56 | -0.9% | -12.6% | +9.9% | |
| Nov 9, 2021 | Rasmussen Randy66 | Chief Financial Officer | Sell | 7,185 | $73.98 | $531,541.27 | -8.5% | -58.3% | -70.0% | |
| Nov 8, 2021 | Linetsky David71 | SVP, Life Sciences | Sale+OE | 4,977 | $75.14 | $373,989.46 | -1.7% | -58.6% | -69.4% | |
| Nov 1, 2021 | Linetsky David71 | SVP, Life Sciences | Sale+OE | 5,451 | $70.88 | $386,361.72 | -1.9% | -56.2% | -61.9% | |
| Oct 15, 2021 | Linetsky David71 | SVP, Life Sciences | Sale+OE | 5,452 | $65.36 | $356,334.00 | -3.7% | -45.2% | -64.7% | |
| Sep 1, 2021 | Linetsky David71 | SVP, Life Sciences | Sale+OE | 5,452 | $70.54 | $384,587.11 | -1.0% | -17.0% | -64.8% | |
| Aug 30, 2021 | Indig Chaim71 | Chief Executive Officer | Sale+OE | 112,228 | $71.83 | $8,061,717.77 | -1.2% | -17.0% | -66.9% | |
| Aug 27, 2021 | Linetsky David71 | SVP, Life Sciences | Sale+OE | 21,455 | $71.85 | $1,541,599.23 | -3.5% | -16.9% | -67.7% |